1. Home
  2. Companies
  3. OSX
  4. Material Events

Osteopore (ASX:OSX) — Material Events

ASX:OSX · 25 articles in the last 12 months · 100% assessed

Click a band to jump to that tier

Significant 16 articles Notable 9 articles Not Assessed 0 articles
Major ≥90 Significant 75–89 Notable 50–74 Routine <50 Not assessed
Significant Score 75–89
16
Osteopore Reports 10% Quarterly Revenue Growth, Expands Asia Pacific PartnershipsMedium
Osteopore reports 10% QoQ revenue growth, expands Asia Pacific partnerships and product innovations in Q1 CY26
30 Apr 2026 ·Quarterly Report ·85
Osteopore Breaks Revenue Records and Gains EU Approval for Custom ImplantsMedium
Osteopore posts record Q2 revenue, secures EU MDR clearance, and advances clinical studies
31 July 2025 ·Quarterly Report ·85
Osteopore Launches OsteoRx with AUD 0.5m to Pioneer Cellular RegenerationMedium
Osteopore launches OsteoRx SPV with AUD 0.5m investment to expand regenerative medicine footprint
1 Sept 2025 ·Strategic Investment Announcement ·85
Osteopore Expands into China with Exclusive RMB 12m DealMedium
Osteopore secures exclusive RMB 12m distribution deal with Majeton for China market expansion
16 Jan 2026 ·Commercial Agreement Announcement ·85
Osteopore and DKSH Forge 5-Year Deal to Transform Malaysia’s Dental Regeneration MarketMedium
Osteopore inks 5-year deal with DKSH Malaysia to expand dental product distribution
25 Nov 2025 ·Commercial Partnership Announcement ·80
Osteopore Accelerates Growth with Swiss Approval and Expanding Global SalesMedium
Osteopore posts 7% YoY revenue growth, gains Swiss market approval, expands sales via Zimmer Biomet partnership, and wins Vietnam hospital tenders
31 Oct 2025 ·Quarterly Report ·80
Osteopore Secures Exclusive Deal to Enter China’s Lucrative Implant MarketMedium
Osteopore inks exclusive deal with Majeton for Chinese market access
16 Jan 2026 ·Commercial Collaboration Agreement ·80
Osteopore Targets Hong Kong Orthopaedic Market with Exclusive MontsMed DealMedium
Osteopore expands orthopaedic business into Hong Kong via exclusive MontsMed deal
22 Jan 2026 ·Market Expansion Announcement ·75
Osteopore Gains Strategic Hainan Approval for Orthopaedic Devices with First Surgery SetMedium
Osteopore secures Hainan FDA approval for custom orthopaedic devices with first surgery scheduled June 2026
26 May 2026 ·Regulatory Approval ·75
Osteopore Advances with 6% Revenue Growth Amid Rising Losses and Regulatory GainsMedium
Osteopore reports 6% revenue growth, $1.63M loss, expands regulatory approvals and distribution
29 Aug 2025 ·Appendix 4D and Interim Financial Report ·75
Osteopore Expands SEA Reach with Injectable Bone Filler Distribution DealMedium
Osteopore secures SEA distribution rights for injectable bone filler, expanding orthopaedic portfolio
12 Mar 2026 ·Distribution Agreement Announcement ·75
Osteopore Secures Singapore Rights for Game-Changing Dental Graft TechMedium
Osteopore secures Singapore distribution rights for autologous dentin graft technology, targeting ASEAN/APAC expansion
3 Mar 2026 ·ASX Announcement ·75
Osteopore Grows Revenue 30% Despite Regional Challenges, Seals DKSH DealMedium
Osteopore posts 30% revenue growth in Q4 CY25 and inks 5-year DKSH Malaysia dental partnership
30 Jan 2026 ·Quarterly Report ·75
Osteopore’s Sales Triple in First Year with Zimmer Biomet PartnershipMedium
Osteopore reports three-fold sales growth via Zimmer Biomet distribution in first year
29 July 2025 ·Business Update ·75
Osteopore Secures Swiss Approval, Unlocking New European GrowthMedium
Osteopore gains Swiss market approval for 3D-printed implants under EU MDR
14 July 2025 ·Market Approval Announcement ·75
Osteopore Expands Latin America Reach with Medprin PartnershipMedium
Osteopore inks exclusive Latin America craniofacial distribution deal with Medprin
13 Feb 2026 ·Partnership Announcement ·75
Notable Score 50–74
9
Osteopore Grows Revenue 11% Amid Rising Losses and Expansion in SingaporeMedium
Osteopore posts 11% revenue growth but wider net loss of $3.72M for 2025, expands Singapore subsidiary
27 Feb 2026 ·Appendix 4E Preliminary Final Report ·70
Osteopore Taps Hong Kong Gateway to Expand Orthopaedic ReachMedium
Osteopore expands orthopaedic business into Hong Kong via exclusive MontsMed agreement
22 Jan 2026 ·ASX Announcement ·70
Osteopore Secures Key Vietnam Hospital Tenders, Eyeing APAC Orthopaedic GrowthMedium
Osteopore wins Vietnam public hospital tenders for orthopaedic products
4 Aug 2025 ·ASX Announcement ·65
Not Assessed Low Score, or missing data
0

No articles in this tier for the last 12 months.